GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Gross Margin %

Sophia Genetics (Sophia Genetics) Gross Margin % : 65.94% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Sophia Genetics's Gross Profit for the three months ended in Mar. 2024 was $10.41 Mil. Sophia Genetics's Revenue for the three months ended in Mar. 2024 was $15.78 Mil. Therefore, Sophia Genetics's Gross Margin % for the quarter that ended in Mar. 2024 was 65.94%.


The historical rank and industry rank for Sophia Genetics's Gross Margin % or its related term are showing as below:

SOPH' s Gross Margin % Range Over the Past 10 Years
Min: 62.29   Med: 65.71   Max: 70.3
Current: 67.97


During the past 6 years, the highest Gross Margin % of Sophia Genetics was 70.30%. The lowest was 62.29%. And the median was 65.71%.

SOPH's Gross Margin % is ranked better than
76.35% of 609 companies
in the Healthcare Providers & Services industry
Industry Median: 41.4 vs SOPH: 67.97

Sophia Genetics had a gross margin of 65.94% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Sophia Genetics was 0.00% per year.


Sophia Genetics Gross Margin % Historical Data

The historical data trend for Sophia Genetics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Gross Margin % Chart

Sophia Genetics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 70.30 62.29 62.35 65.71 68.80

Sophia Genetics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.41 66.74 69.15 69.80 65.94

Competitive Comparison of Sophia Genetics's Gross Margin %

For the Health Information Services subindustry, Sophia Genetics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sophia Genetics's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's Gross Margin % falls into.



Sophia Genetics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Sophia Genetics's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=42.9 / 62.371
=(Revenue - Cost of Goods Sold) / Revenue
=(62.371 - 19.458) / 62.371
=68.80 %

Sophia Genetics's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=10.4 / 15.779
=(Revenue - Cost of Goods Sold) / Revenue
=(15.779 - 5.374) / 15.779
=65.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sophia Genetics  (NAS:SOPH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sophia Genetics had a gross margin of 65.94% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Sophia Genetics Gross Margin % Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sophia Genetics (Sophia Genetics) Business Description

Traded in Other Exchanges
Address
Rue du Centre 172, Saint-Sulpice, CHE, CH-1025
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.